Header Logo

Connection

LYNN ZECHIEDRICH to Escherichia coli

Back to Details
This is a "connection" page, showing publications LYNN ZECHIEDRICH has written about Escherichia coli.
LYNN ZECHIEDRICH
Connection Strength
2.970
Escherichia coli
  1. Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli. PLoS One. 2019; 14(1):e0210547.
    View in: PubMed
    Score: 0.425
  2. Escherichia coli DNA ligase B may mitigate damage from oxidative stress. PLoS One. 2017; 12(7):e0180800.
    View in: PubMed
    Score: 0.383
  3. Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae. PLoS One. 2013; 8(7):e69646.
    View in: PubMed
    Score: 0.291
  4. Novel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical Isolates. PLoS One. 2013; 8(6):e65961.
    View in: PubMed
    Score: 0.289
  5. Editorial comment to genome-wide transcriptome analysis of fluoroquinolone resistance in clinical isolates of Escherichia coli. Int J Urol. 2012 Apr; 19(4):368-9.
    View in: PubMed
    Score: 0.265
  6. Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother. 2011 Feb; 55(2):921-4.
    View in: PubMed
    Score: 0.242
  7. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob Agents Chemother. 2009 Jan; 53(1):235-41.
    View in: PubMed
    Score: 0.209
  8. Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates. Antimicrob Agents Chemother. 2009 Jan; 53(1):229-34.
    View in: PubMed
    Score: 0.209
  9. Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location. BMC Infect Dis. 2008 Jan 15; 8:4.
    View in: PubMed
    Score: 0.199
  10. Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother. 2007 Nov; 51(11):4205-8.
    View in: PubMed
    Score: 0.193
  11. Structural basis of DNA crossover capture by Escherichia coli DNA gyrase. Science. 2024 04 12; 384(6692):227-232.
    View in: PubMed
    Score: 0.153
  12. Temporal interplay between efflux pumps and target mutations in development of antibiotic resistance in Escherichia coli. Antimicrob Agents Chemother. 2012 Apr; 56(4):1680-5.
    View in: PubMed
    Score: 0.065
  13. Hin-mediated DNA knotting and recombining promote replicon dysfunction and mutation. BMC Mol Biol. 2007 May 25; 8:44.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.